Chester County News and Community Website
PHILADELPHIA, PA — Century Therapeutics, Inc. (NASDAQ: IPSC) has announced its participation in the upcoming European Alliance of Associations for Rheumatology (EULAR) 2025 Congress, set to take place from June …
Century Therapeutics to Present Preclinical Data at EULAR 2025 Congress Read More PHILADELPHIA, PA — Century Therapeutics, Inc. (NASDAQ: IPSC) reported notable progress in Q1 2025, emphasizing advancements in its clinical and preclinical iPSC-derived cell therapy programs. Highlights include updates on the …
Century Therapeutics Reports Positive Q1 2025 Results and Advances in Cell Therapy Pipeline Read More PHILADELPHIA, PA — Century Therapeutics, Inc. (NASDAQ: IPSC) has announced two critical presentations at the 28th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT), taking place …
Century Therapeutics to Showcase Promising Cell Therapy Data at ASGCT Annual Meeting Read More PHILADELPHIA, PA — Century Therapeutics, Inc. (NASDAQ: IPSC) announced that its management team will host a live fireside chat on Tuesday, April 22, 2025, at 10:00 a.m. EDT to discuss …
Century Therapeutics Hosts Live Fireside Chat on Groundbreaking Cell Therapy Advances Read More PHILADELPHIA, PA — Century Therapeutics, Inc. (NASDAQ: IPSC) outlined a strategic pipeline re-prioritization and shared its financial results for the year 2024. This move aims to focus on potentially groundbreaking programs …
Century Therapeutics Announces Strategic Pipeline Shift and 2024 Financial Results Read More PHILADELPHIA, PA — Century Therapeutics, Inc. (NASDAQ: IPSC) has cemented a collaboration with renowned cell therapy leaders Professors Georg Schett and Andreas Mackensen to initiate a Phase 1/2 trial exploring its …
Century Therapeutics Partners with Experts for New Trial on Autoimmune Diseases Read More PHILADELPHIA, PA — Century Therapeutics, Inc. (NASDAQ: IPSC) has announced its financial results and business updates for the third quarter of 2024, highlighting significant progress in its clinical trials and …
Century Therapeutics Expands Clinical Focus and Reports Steady Financials for Q3 2024 Read More PHILADELPHIA, PA — Century Therapeutics, Inc. (NASDAQ: IPSC) has announced key leadership changes with the appointments of Morgan Conn, Ph.D., as Chief Financial Officer and Chad Cowan, Ph.D., as Chief …
Century Therapeutics Announces Strategic Leadership Appointments Read More PHILADELPHIA, PA — Century Therapeutics, Inc. (NASDAQ: IPSC) has announced its financial results for the second quarter ending June 30, 2024, along with key business updates.
Century Therapeutics Reports Q2 2024 Financial Results and Business Highlights Read More PHILADELPHIA, PA — Emerging from the recent ASGCT 27th Annual Meeting, Century Therapeutics (NASDAQ: IPSC) has caught the attention of the medical world. The company revealed its innovative Allo-Evasion™ platform, …
Revolutionary Leap in Biotherapy: Century Therapeutics’ Ground-Breaking Technology Proves Promising Read More